NeuroMetrix (NURO)
Create an AlertNeuroMetrix News
Neurometrix (NURO) Files 3.98M Common Shelf for Shareholders
Street Insider Jun 17NeuroMetrix to Exhibit at American Diabetes Association’s 73rd Scientific Sessions
Business Wire Jun 10NeuroMetrix, Inc. , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that it will exhibit and participate in the American Diabetes Association’s 73rd Scientific Sessions.
Unusual 11 Mid-Day Movers 06/05: (KNDI) (HNR) (LAS) Higher; (NURO) (AMPE) (ZGNX) Lower
Street Insider Jun 5NeuroMetrix (NURO) Places $5M of Convertible Preferred
Street Insider Jun 5NeuroMetrix Announces $5 Million Preferred Stock Placement
Business Wire Jun 4NeuroMetrix, Inc. , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that it entered into a definitive securities purchase agreement with a single institutional investor providing for the issuance of $5,000,000 of shares of Series A-1 and Series A-2 convertible preferred stock and five year warrants to purchase up to 2,386,635 ...
NeuroMetrix's CEO Discusses Q12013 Results - Earnings Call Transcript
Seeking Alpha Apr 25NeuroMetrix's CEO Discusses Q12013 Results - Earnings Call Transcript
NeuroMetrix Reports Q1 2013 Results
Business Wire Apr 25NeuroMetrix, Inc. , a medical device company focused on the treatment of diabetic peripheral neuropathy , today reported business and financial highlights for the first quarter ended March 31, 2013.
NeuroMetrix to Partner with Omron Healthcare for Distribution of NC-stat DPNCheck in Japan
Business Wire Apr 24WALTHAM, Mass.--(BUSINESSWIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), announced that it had entered into an agreement ...
NeuroMetrix, Inc. Announces Date for 2013 First Quarter Financial Results Conference Call
Business Wire Apr 17NeuroMetrix, Inc. , today said it plans to issue its 2013 first quarter financial results before the opening of the market on April 25, 2013. The Company will host a
NeuroMetrix Enters Exclusive Distribution Agreement with Handok Pharmaceuticals in Republic of Korea
Benzinga Mar 12NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of Korea
Business Wire Mar 12NeuroMetrix, Inc. , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has entered an agreement with Handok Pharmaceuticals, Inc.
NEUROMetrix (NURO) Files $20M Mixed Shelf
Street Insider Feb 25Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NURO | 2.00 | -0.02 | -0.99% | 4.517M |
